In vivo evaluation of mebendazole and Ran GTPase inhibition in breast cancer model system.

MLA

Abu-Hdaib, Balqis, et al. “In Vivo Evaluation of Mebendazole and Ran GTPase Inhibition in Breast Cancer Model System.” Nanomedicine, vol. 19, no. 12, May 2024, pp. 1087–101. EBSCOhost, https://doi.org/10.2217/nnm-2023-0351.

APA

Abu-Hdaib, B., Nsairat, H., El-Tanani, M., Al-Deeb, I., & Hasasna, N. (2024). In vivo evaluation of mebendazole and Ran GTPase inhibition in breast cancer model system. Nanomedicine, 19(12), 1087–1101. https://doi.org/10.2217/nnm-2023-0351

Chicago

Abu-Hdaib, Balqis, Hamdi Nsairat, Mohamed El-Tanani, Ibrahim Al-Deeb, and Nabil Hasasna. 2024. “In Vivo Evaluation of Mebendazole and Ran GTPase Inhibition in Breast Cancer Model System.” Nanomedicine 19 (12): 1087–1101. doi:10.2217/nnm-2023-0351.